Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

BACKGROUND: In a phase III, open-label, comparative, noninferiority study, 638 subjects receiving de novo kidney transplants were randomized to one of three treatment arms: tacrolimus extended-release (Astagraf XL) qd, tacrolimus (Prograf) bid, or cyclosporine (CsA) bid. All subjects received basili...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Hélio Tedesco, Yang, Harold C., Meier-Kriesche, Herwig-Ulf, Croy, Richard, Holman, John, Fitzsimmons, William E., First, M. Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979830/
https://www.ncbi.nlm.nih.gov/pubmed/24521771
http://dx.doi.org/10.1097/01.TP.0000437669.93963.8E

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979830/
https://www.ncbi.nlm.nih.gov/pubmed/24521771
http://dx.doi.org/10.1097/01.TP.0000437669.93963.8E

Ejemplares similares